pamidronate has been researched along with strontium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cukrowski, I; Jackson, GE; Jarvis, NV; Louw, WK; Mouton, CJ; Zeevaart, JR | 1 |
| Taguchi, T | 1 |
1 review(s) available for pamidronate and strontium
| Article | Year |
|---|---|
[Encounter of cancer cells with bone. Treatment of bone metastases from breast cancer].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Denosumab; Diphosphonates; Female; Humans; Imidazoles; Molecular Targeted Therapy; Osteoclasts; Pamidronate; RANK Ligand; Strontium; Zoledronic Acid | 2011 |
1 other study(ies) available for pamidronate and strontium
| Article | Year |
|---|---|
Metal-ion speciation in blood plasma incorporating the bisphosphonate, 1-hydroxy-4-aminopropilydenediphosphonate (APD), in therapeutic radiopharmaceuticals.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Holmium; Molecular Structure; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Pamidronate; Papio; Potentiometry; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Strontium | 1999 |